PR Domain Containing 1, with ZNF Domain (PRDM1) Peptide
Quick Overview for PR Domain Containing 1, with ZNF Domain (PRDM1) Peptide (ABIN8108783)
Target
Source
Application
-
-
Purpose
- PRDM1 Peptide
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-PRDM1 antibody ( ARP38013_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- PRDM1 (PR Domain Containing 1, with ZNF Domain (PRDM1))
-
Background
-
Background Information: PRDM1 is a protein that acts as a repressor of beta-interferon gene expression. The protein binds specifically to the PRDI (positive regulatory domain I element) of the beta-IFN gene promoter. Transcription of this gene increases upon virus induction. Two alternatively spliced transcript variants that encode different isoforms have been reported.
Alternative Symbols: BLIMP1, PRDI-BF1
-
Molecular Weight
- 88kDa
-
Gene ID
- 639
-
NCBI Accession
- NP_001189
-
UniProt
- O75626
Target
-